|12-07-2018 11:16 AM CET - Health & Medicine||
2018 Comprehensive Evaluation on Digital Genome Market|Key Players are: Illumina, Agilent Technologies, Fluidigm Corporation
Press release from: Global Market Insights
Global Digital Genome Market was over USD 20 billion in 2015, with expectations to witness around 9.5% CAGR from 2016 to 2024. Increasing investments and funding for life sciences research will drive the sequencing & analyzer instruments demand over the coming years. The segment accounted for over 40% of digital genome market share in 2015.
Sequencing and analysis software should witness 9.8% growth due to technological improvements in software packages for production and analysis of sequence data. A large number of software tools are under development for increased data automation.
Request for a sample of this research report @ www.gminsights.com/request-sample/detail/1219
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• BioMarin Pharmaceutical Inc.
• Agilent Technologies
• Fluidigm Corporation
• Pacific Biosciences
• Agios Pharmaceuticals
• AVEO Oncology
• Thermo Fisher Scientific
• PerkinElmer, Inc.
Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth. Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.
Biopharmaceutical companies contributed more than 45% to the digital genome market share in 2015. Extensive application of genome sequencing technologies for development of targeted therapies should spur industry growth. Other industry segments such as hospitals, research institutes and diagnostic laboratories should strive to seize business share over the coming years.
U.S. digital genome market share was more than 80% of the North American revenue in 2015. The well-established healthcare infrastructure, discovery of new genome sequencing technologies and increasing geriatric population will contribute towards revenue growth.
Make an inquiry for purchasing this report @ www.gminsights.com/inquiry-before-buying/1219
Academic research institutes are set to witness high growth owing to increasing funding from investors for development of novel technologies, instruments and services. Early investors are trying to reap significant profits by investing in relatively new and less explored ecosystem.
Digital Genome Market By End-Use
• Diagnostics & Forensic Labs
• Academic Research Institutes
• Bio-pharmaceutical companies
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Toll Free: 1-888-689-0688
This release was published on openPR.
News-ID: 1424857 • Views: 324More releases